Ignite Creation Date:
2024-10-25 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06654219
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-21
Brief Title:
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor GLP-1 RA Agonist Prior to Anesthesia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor Agonist Prior to Anesthesia
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if prolonged fasting from solids and transitioning to a CLD for 24 hours is protective to decrease RGC in patients on GLP-1 RAs presenting for upper endoscopy to determine if prolonged fasting is associated with increased thirst hunger and anxiety To determine if signs and symptoms of nausea vomiting retching abdominal bloating and abdominal pain are present on the day of surgery to see if there is any variability between preoperative gastric ultrasound assessment and volume of gastric contents visualized on upper endoscopy to determine time of gastric emptying by serial Gastric ultrasonography GUS scans every 2 hours in subjects who presented with an initial at-risk scan to determine the choice of anesthesia used based on preoperative GUS results to determine if there were any adverse events recorded in this study group to determine if duration of GLP-1 RA therapy has an association with residual gastric content RGC and to determine if dosing of GLP-1 RA has an association with RGC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None